Fein; Seymour H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fein; Seymour H..The latest application filed is for "methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist".

Company Profile

2.9.13

Fein; Seymour H. - New Canaan CT
Fein; Seymour H. - New Canann CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist Grant 10,568,927 - Fein , et al. Feb	2020-02-25
Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist Grant 10,286,033 - Fein , et al.	2019-05-14
Methods And Compositions Comprising Desmopressin In Combination With A Beta-3-adrenergic Receptor Agonist App 20180289769 - Fein; Seymour H. ; et al.	2018-10-11
Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor Grant 9,925,232 - Fein , et al. March 27, 2	2018-03-27
Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist Grant 9,814,753 - Fein , et al. November 14, 2	2017-11-14
Methods And Compositions Comprising Desmopressin In Combination With An Alpha-adrenergic Receptor Antagonist App 20170319646 - Fein; Seymour H. ; et al.	2017-11-09
Methods And Devices For Desmopressin Drug Delivery App 20160303185 - Herschkowitz; Samuel ; et al.	2016-10-20
Methods and devices for desmopressin drug delivery Grant 9,375,530 - Herschkowitz , et al. June 28, 2	2016-06-28
Methods And Compositions Comprising Desmopressin In Combination With A 5-alpha Reductase Inhibitor App 20150031614 - Fein; Seymour H. ; et al.	2015-01-29
Methods And Compositions Comprising Desmopressin In Combination Wtih A Beta-3-adrenergic Receptor Agonist App 20150031613 - Fein; Seymour H. ; et al.	2015-01-29
Methods And Devices For Desmopressin Drug Delivery App 20140058313 - Herschkowitz; Samuel ; et al.	2014-02-27
Pharmaceutical Compositions Including Low Dosages of Desmopressin App 20120322734 - Fein; Seymour H.	2012-12-20
Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis Grant 7,947,285 - Fein , et al. May 24, 2	2011-05-24
Pharmaceutical compositions including low dosages of desmopressin Grant 7,799,761 - Fein September 21, 2	2010-09-21
Pharmaceutical Compositions Including Low Dosages Of Desmopressin App 20090005432 - Fein; Seymour H.	2009-01-01
Pharmaceutical Compositions Including Low Dosages Of Desmopressin App 20080274951 - Fein; Seymour H.	2008-11-06
Pharmaceutical compositions including low dosages of desmopressin Grant 7,405,203 - Fein July 29, 2	2008-07-29
Methods for treatment of acute pancreatitis Grant 7,381,698 - Fein , et al. June 3, 2	2008-06-03
Pharmaceutical Compositions Including Low Dosages of Desmopressin App 20070265207 - Fein; Seymour H.	2007-11-15
Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis App 20060002912 - Fein; Seymour H. ; et al.	2006-01-05
Methods for treatment of acute pancreatitis App 20050129675 - Fein, Seymour H. ; et al.	2005-06-16
Pharmaceutical compositions including low dosages of desmopressin App 20040138098 - Fein, Seymour H.	2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.